Your search for vaccination returned 4114 results

Investigators sought to evaluate the association between the development of atopic dermatitis (AD) and pre- and postnatal antibiotic exposure.

Researchers sought to assess inpatient management and post-discharge sequelae in children with critical respiratory illness due to influenza.

A systematic review of the published literature is conducted to collect data regarding chronic dermatoses exacerbation after COVID-19 vaccination.

Researchers sought to assess the extent of neurologic involvement caused by SARS-CoV-2 in children and adolescents in the US.

Prior infection with SARS-CoV-2 is not associated with death, major adverse CVD events, or rehospitalization following elective major noncardiac surgery.

Researchers evaluated the effectiveness of bivalent mRNA COVID-19 vaccination among adults who previously received at least 2 monovalent vaccine doses.

Researchers evaluated the incidence of monkeypox infection among unvaccinated men and those who received either 1 or 2 doses of the JYNNEOS vaccine.

The odds of experiencing major postoperative cardiovascular morbidity are reduced with increased time from COVID-19 diagnosis to surgery.

The bivalent vaccine contains the original strain of the SARS-CoV-2 virus and a strain from the BA.4 and BA.5 lineages of the Omicron variant.

Researchers sought to determine whether COVID-19 reinfection adds to risks incurred after an initial infection.

Although this year’s ultra-high rates of RSV hospitalizations have recently fallen, certain features of this season’s outbreak set it apart from those of previous years.

Nirmatrelvir plus ritonavir reduces the risk for hospitalization or death after an outpatient diagnosis of COVID-19 among older adults.

A New Zealand population study examined the effect of maternal influenza vaccination on birth outcomes.

The BLA is supported by data from the phase 3 RENOIR trial which included approximately 37,000 adults 60 years of age and older.

Syphilis diagnoses have continued to accelerate for the past few years due to COVID-19 pandemic-related restrictions at sexual health clinics.

As three highly contagious respiratory viruses spread across the US, health officials in major cities and states are calling for a return to indoor masking.

A meta-analysis of 2000 to 2001 data estimated the disease burden of respiratory syncytial virus among adults at least 60 years of age in high-income countries.

More than half of U.S. adults say they are not very or not at all concerned about the upcoming influenza season.

The bivalent vaccine contains the original strain of the SARS-CoV-2 virus and a strain from the BA.4 and BA.5 lineages of the Omicron variant.

Researchers evaluated the safety and immunogenicity of VLA1553, a live attenuated vaccine candidate for protection against Chikungunya virus infection.

Patients with COVID-19 taking molnupiravir or nirmatrelvir-ritonavir rarely have viral rebound, and rebound is not associated with increased mortality risk.

Investigators sought to evaluate outcomes of SARS-CoV-2 vaccination and COVID-19 in adult patients treated with tralokinumab for atopic dermatitis (AD).

A meta-analysis assessed use of fluvoxamine, a drug used to treat depression, for preventing hospitalization among those with COVID-19 infection.

Researchers evaluated the safety and immunogenicity of a booster dose of the Ad26.ZEBOV vaccine for protection against Ebola virus disease in children.

One in seven U.S. parents have not talked about vaccines with their child’s regular provider in the past two years.

Researchers assessed maternal antibody responses and transplacental transfer among women who were infected with or vaccinated against COVID-19 during pregnancy.

Is there an association between drug use and severe influenza-associated outcomes, including ICU admission, mechanical ventilation, and death?

Researchers evaluated the effect of influenza vaccination on reducing antibiotic prescription outcomes for adults diagnosed with influenza-like illness.

Researchers evaluated the antiviral efficacy of molnupiravir among vaccinated and unvaccinated patients infected with a broad range of COVID-19 variants.

Veterans with PTSD and other psychiatric disorders have a heightened risk for severe adverse outcomes with COVID-19.